News

: StealthEnomics; Medical - Translational; 05 October 2016; Hits: 587; Rating:

Building Evidence: Effective Palliative/End of Life Care Interventions (R01)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 6-10-2019

Funding Opportunity : PAR-16-250

CFDA : 93.361|000000

Agency : Department of Health and Human Services

Contact : NIH OER Webmaster
This email address is being protected from spambots. You need JavaScript enabled to view it.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Eligibility : State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Native American Tribal Governments (Federally recognized)
Public Housing Authorities/Indian Housing Authorities
Native American Tribal Organizations (other than Federally recognized tribal governments)
Nonprofits Having a 501 (c) (3) Status with the IRS (other than institutions of higher education)
Nonprofits that do not have a 501 (c) (3) status with the IRS (other than institutions of higher education)
Private institutions of higher education
For-profit organizations other than small business
Small businesses
Others

Details :
This funding opportunity announcement (FOA) seeks to stimulate research that tests optimal end-of-life and palliative care (EOLPC) interventions/models of care that are based on individual- and family-centered outcomes. The testing of EOLPC interventions and models of care are urgently needed that address racial, ethnic and/or cultural diversity in children and adults for those with serious, advanced illness. Trials are needed to test efficacy and effectiveness of these interventions and/or models of care.

Tags: Health, Education

: StealthEnomics; Medical - Translational; 05 October 2016; Hits: 547; Rating:

Prescription Drug Abuse (R01)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 5-7-2019

Funding Opportunity : PA-16-233

CFDA : 93.279|000000

Agency : Department of Health and Human Services

Details :
This Funding Opportunity Announcement (FOA) encourages applicants to develop innovative research applications on prescription drug abuse, including research to examine the factors contributing to prescription drug abuse; to characterize the adverse medical, mental health and social consequences associated with prescription drug abuse; and to develop effective prevention and service delivery approaches and behavioral and pharmacological treatments. Applications to address these issues are encouraged across a broad range of methodological approaches including basic science, clinical, epidemiological, and health services research to define the extent of the problem of prescription drug abuse, to characterize this problem in terms of classes of drugs abused and combinations of drug types, etiology of abuse, and populations most affected (including analyses by age group, race/ethnicity, gender, and psychiatric symptomatology). Studies on individual- and patient-level factors, prescriber factors, and/or health system factors are encouraged, as are studies on all classes of prescription drugs with high abuse liability, including analgesics, stimulants, sedative/hypnotics and anxiolytics. Researchers are further encouraged to study the relationship between the prescription medication, the indication for which the medication was prescribed (e.g., pain, sleep disorder, anxiety disorder, obesity), and the environmental and individual factors contributing to abuse.

Tags: Health, Education

: StealthEnomics; Medical - Translational; 05 October 2016; Hits: 613; Rating:

Gene Fusions in Pediatric Sarcomas (R01)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 5-7-2019

Funding Opportunity : PA-16-251

CFDA : 93.396|000000

Agency : Department of Health and Human Services

Details :
The overall goal of this funding opportunity announcement (FOA) is to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.

Tags: Health, Education

: StealthEnomics; Medical - Translational; 03 September 2016; Hits: 491; Rating:

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 7-28-2016

Funding Opportunity : RFA-DA-17-015

CFDA : 93.279|000000

Agency : Department of Health and Human Services

Details :
The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use.Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum. The ultimate goal of this FOA is to bring molecules closer to FDA approval.

Tags: Health, Education

: StealthEnomics; Medical - Translational; 03 September 2016; Hits: 553; Rating:

The Application of Big Data Analytics to Drug Abuse Research (R01)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 5-7-2019

Funding Opportunity : PA-16-119

CFDA : 93.279|000000

Agency : Department of Health and Human Services

Details :
The purpose of this FOA is to encourage the application of Big Data analytics to reveal deeper or novel insights into the biological and behavioral processes associated with substance abuse and addiction.NIDA recognizes that to accelerate progress toward understanding how the human brain and behavior is altered by chronic drug use and addiction, it is vital to develop more powerful analytical methods and visualization tools that can help capture the richness of data being generated from genetic, epigenetic, molecular, proteomic, metabolomic, brain-imaging, micro-electrode, behavioral, clinical, social, services, environmental studies as well as data generated from electronic health records.Applications for this FOA should develop and/or utilize computational approaches for analyzing large, complex datasets acquired from drug addiction research.The rapid increase of technologies to acquire unprecedented amounts of neurobiological and behavioral data, and an expanding capacity to store those data, results in great opportunity to bring to bear the power of the computational methods of Big Data analytics on drug abuse and addiction.

Tags: Health, Education

Message

Building Evidence: Effective Palliative/End of Life Care Interventions (R01)

Programming Grants to Accompany NEH on the Road Exhibitions

Prescription Drug Abuse (R01)

Programming Grants to Accompany NEH on the Road Exhibitions

Gene Fusions in Pediatric Sarcomas (R01)

Programming Grants to Accompany NEH on the Road Exhibitions

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)

Programming Grants to Accompany NEH on the Road Exhibitions

The Application of Big Data Analytics to Drug Abuse Research (R01)

Programming Grants to Accompany NEH on the Road Exhibitions

Grant Deadline Feeds

Search